Cargando…
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA
PURPOSE: Physical examinations and annual mammography (minimal follow-up) are as effective as laboratory/imaging tests (intensive follow-up) in detecting breast cancer (BC) recurrence. This statement is now challenged by the availability of new diagnostic tools for asymptomatic cases. Herein, we ana...
Autores principales: | La Rocca, E., De Santis, M. C., Silvestri, M., Ortolan, E., Valenti, M., Folli, S., de Braud, F. G., Bianchi, G. V., Scaperrotta, G. P., Apolone, G., Daidone, M. G., Cappelletti, V., Pruneri, G., Di Cosimo, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114063/ https://www.ncbi.nlm.nih.gov/pubmed/35396978 http://dx.doi.org/10.1007/s00432-022-03990-7 |
Ejemplares similares
-
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
por: Ortolan, E., et al.
Publicado: (2021) -
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world
por: Di Cosimo, Serena, et al.
Publicado: (2022) -
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer
por: Silvestri, Marco, et al.
Publicado: (2022) -
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy
por: Di Cosimo, Serena, et al.
Publicado: (2019) -
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer
por: Reduzzi, Carolina, et al.
Publicado: (2021)